HER2 Support Group Forums - View Single Post - Phase 1 results point to larger trial of enzalutamide and fulvestrant in breast cance

News · 12-08-2015, 07:20 AM

Results of a multicenter phase 1 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium show that the anti-androgen agent enzalutamide is active and well-tolerated alone and with...

More...

12-08-2015, 07:20 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,155	Phase 1 results point to larger trial of enzalutamide and fulvestrant in breast cance Results of a multicenter phase 1 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium show that the anti-androgen agent enzalutamide is active and well-tolerated alone and with... More...